pentetic acid has been researched along with scandium in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, WT; Strand, M | 1 |
Rosoff, B; Spencer, H | 1 |
Cai, W; Chakravarty, R; Goel, S; Hernandez, R; Hong, H; Nickles, RJ; Valdovinos, HF | 1 |
3 other study(ies) available for pentetic acid and scandium
Article | Year |
---|---|
Stability, targeting, and biodistribution of scandium-46- and gallium-67-labeled monoclonal antibody in erythroleukemic mice.
Topics: Animals; Antibodies, Monoclonal; Drug Stability; Female; Gallium Radioisotopes; Leukemia, Erythroblastic, Acute; Mice; Mice, Inbred BALB C; Pentetic Acid; Radioisotopes; Scandium; Tissue Distribution | 1985 |
Removal of scandium-46 in man.
Topics: Aged; Edetic Acid; Female; Humans; Male; Middle Aged; Pentetic Acid; Radioisotopes; Scandium; Urine | 1965 |
Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment.
Topics: Animals; Brain Neoplasms; Caco-2 Cells; Cetuximab; ErbB Receptors; Female; Flow Cytometry; Glioblastoma; Half-Life; Humans; Immunoglobulin Fab Fragments; Isotope Labeling; Mice, Nude; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Scandium; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |